In addition, we concluded that mir-15b enhanced the proliferation and migration of lung adenocarcinoma by targeting BCL2 (26) and that increased BIRC5 expression could improve the efficacy of radiotherapy for LUAD cells (27). Here, BCL2 is linked to lung adenocarcinoma.